Related Experiment Video
Updated: Jul 10, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
[Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)--a new challenge in the ambulatory
Manuela Buehlmann1, Christian Chuard
1Klinik für Infektiologie und Spitalhygiene, Universitätsspital, 4031 Basel. mbuehlmann@uhbs.ch
Abstract:
In the last decade, community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) have emerged in young, individuals without risk factors for MRSA acquisition. They mainly present with skin and soft tissue infections. CA-MRSA are genotypically and phenotypically differents from HA-MRSA. In case of recurrent or severe soft tissue infections, search for CA-MRSA should be performed. Treatment consists of incision and drainage of abscesses and furuncles. If antibiotics are needed, trimethoprim-sulfamethoxazole is the first choice. A specialist in infection control is advised for contact screening implementation of hygienic precautions and decolonization therapy.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...